PMID- 15779847 OWN - NLM STAT- MEDLINE DCOM- 20050510 LR - 20170511 IS - 0001-5385 (Print) IS - 0001-5385 (Linking) VI - 60 IP - 1 DP - 2005 Feb TI - Intracardiac basic fibroblast growth factor and transforming growth factor-beta 1 mRNA and their proteins expression level in patients with pressure or volume-overload right or left ventricular hypertrophy. PG - 21-5 AB - OBJECTIVES: The aim of the study was to investigate the pathogenic role of intracardiac basic fibroblast growth factor (bFGF) and transforming growth factor beta-1 (TGF beta-1) mRNA and their protein expression level in patients with ventricular volume or pressure-overload. BACKGROUND: Myocardial hypertrophy is responsiveness of cardiomyocytes and interstitial cells to ventricular stress produced by ventricular preload or/and afterload and a series of growth factors. However, the molecular mechanism by which the changes of bFGF and TGF beta-1 mRNA and their protein expression level in patients with volume or pressure-overload lead to distinct forms of cardiac hypertrophy is unclear. METHODS: 32 patients were divided into two groups: 16 patients with cardiac volume overload leading to left ventricular hypertrophy (VG) and 16 patients with pressure overload leading to right ventricular hypertrophy (PG), respectively, as compared with 5 unexpected deaths of noncardiac disease (CG), which is determinated by echocardiography and/or pathologic examination following operation; intracardiac bFGF and TGF beta-1 mRNA and their protein expression level were determined by immunohistochemistry and in situ hybridization as well as image analysis; cardiomyocytes and fibril collagen of type I and III were examined by haemotoxylin and eosin (HE) staining or sirius-red staining. RESULTS: Cardiocyte transverse diameter and fibril collagen of extracellular matrix, intracardiac bFGF and TGF beta-1 mRNA and their protein expression level in patients with volume or pressure-overload were significantly increased in both VG and PG, as compared with CG. CONCLUSION: This is the first paper to suggest that intracardiac bFGF and TGF beta-1 play a pivotal role in patients with pressure or volume-overload leading to right or left ventricular hypertrophy, composed of cardiomyocyte hypertrophy and extracellular matrix proliferation. FAU - He, Zuo Yun AU - He ZY AD - Department of Cardiology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China. yslhzy@yahoo.com.cn FAU - Feng, Bing AU - Feng B FAU - Yang, Sheng Li AU - Yang SL FAU - Luo, Hui Lan AU - Luo HL LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Acta Cardiol JT - Acta cardiologica JID - 0370570 RN - 0 (Biomarkers) RN - 0 (RNA, Messenger) RN - 0 (TGFB1 protein, human) RN - 0 (Transforming Growth Factor beta) RN - 0 (Transforming Growth Factor beta1) RN - 103107-01-3 (Fibroblast Growth Factor 2) SB - IM MH - Adolescent MH - Adult MH - Biomarkers/analysis MH - Biopsy, Needle MH - Blood Chemical Analysis MH - Child MH - Cohort Studies MH - Echocardiography, Doppler MH - Female MH - Fibroblast Growth Factor 2/analysis/*metabolism MH - Heart Function Tests MH - Humans MH - Hypertrophy, Left Ventricular/*metabolism/*physiopathology MH - Immunohistochemistry MH - In Situ Hybridization MH - Male MH - Prognosis MH - RNA, Messenger/analysis MH - Sensitivity and Specificity MH - Severity of Illness Index MH - Transforming Growth Factor beta/analysis/*metabolism MH - Transforming Growth Factor beta1 MH - Ventricular Pressure/*physiology EDAT- 2005/03/23 09:00 MHDA- 2005/05/11 09:00 CRDT- 2005/03/23 09:00 PHST- 2005/03/23 09:00 [pubmed] PHST- 2005/05/11 09:00 [medline] PHST- 2005/03/23 09:00 [entrez] AID - 10.2143/AC.60.1.2005044 [doi] PST - ppublish SO - Acta Cardiol. 2005 Feb;60(1):21-5. doi: 10.2143/AC.60.1.2005044.